Wang, X. (2022) “Stocks Valuation of Johnson & Johnson (J&J): Analysis of Ongoing Risks of Pharmaceuticals Corporations in Post-Pandemic Era”, Highlights in Business, Economics and Management, 1, pp. 36–40. doi:10.54097/hbem.v1i.2315.